• Profile
Close

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on preventing pertussis in infants <2 months of age: A case-control evaluation

Clinical Infectious Diseases Dec 03, 2017

Skoff TH, et al. - A case-control evaluation was performed to assess the effectiveness of 2012 recommendation of providing Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccine to women during each pregnancy to protect infants in the first months of life. Findings demonstrated the efficacy of vaccination during pregnancy in protecting infants during the early months of life. With a continuing resurgence in pertussis, researchers recommended efforts to focus on maximizing Tdap uptake among pregnant women.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay